Moderna said Tuesday that its updated COVID-19 vaccine demonstrated a stronger immune response than its current jab in ...
Goldman Sachs analyst Salveen Richter has maintained their bullish stance on MRNA stock, giving a Buy rating today. Salveen Richter has given ...
Moderna Inc (NASDAQ:MRNA) said that mRNA-1283, the company’s next-generation COVID-19 vaccine, has met the primary endpoints ...
Moderna, Inc. (NASDAQ:MRNA) today announced that mRNA-1283, the Company’s next-generation COVID-19 vaccine, has successfully ...
Moderna, Inc. (MRNA) announced on Tuesday that its next-generation COVID-19 vaccine design mRNA-1283 has met the primary endpoints of ...